MedAlerts Home
  Read the MedAlerts Blog Subscribe to the MedAlerts Blog 

Found 947 cases where Vaccine is VARZOS and Serious

Case Details

This is page 9 out of 95

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18   next


VAERS ID:290869 (history)  Vaccinated:2007-07-06
Age:90.0  Onset:2007-07-07, Days after vaccination: 1
Gender:Female  Submitted:2007-09-05, Days after onset: 60
Location:New York  Entered:2007-09-19, Days after submission: 14
Life Threatening? No
Died? Yes
   Date died: 2007-07-28
   Days after onset: 21
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Synthroid, Metoprolol, Lisinopril, Digitek, Zoloft, Warfarin, B-12 supplement
Current Illness: None
Preexisting Conditions: Hypothyroid, Atrial Fib, CHF, high blood pressure PMH: depression, osteoporosis, mitral regurgitation, dysuria, hyponatremia, anemia, B12 deficiency.
Diagnostic Lab Data: Complete Blood Work, Blood Cultures, on heart monitor, CT scan of Brain (3x), EEG - all normal LABS: EKG revealed a-fib & bradycardia.
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
Administered by: Private     Purchased by: Other
Symptoms: Anaemia, Asthenia, Atrial fibrillation, Blood culture negative, Blood test normal, Bradycardia, Cardio-respiratory arrest, Computerised tomogram normal, Confusional state, Contusion, Death, Dysphagia, Electrocardiogram abnormal, Electroencephalogram normal, Facial palsy, Fall, Full blood count normal, Gait disturbance, Hypertension, Hypothyroidism, Incontinence, Lethargy, Memory impairment, Mental status changes, Mitral valve incompetence, Somnolence, Speech disorder, Staring, Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Haematopoietic erythropenia (broad), Peripheral neuropathy (broad), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (narrow), Arrhythmia related investigations, signs and symptoms (broad), Supraventricular tachyarrhythmias (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Dementia (broad), Parkinson-like events (broad), Acute central respiratory depression (broad), Psychosis and psychotic disorders (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Hypertension (narrow), Cardiomyopathy (broad), Hypothyroidism (narrow), Depression (excl suicide and self injury) (broad), Hypotonic-hyporesponsive episode (broad)
Write-up: Shot (vaccine) given 7/6/07. 7/7/07 Somewhat not responding to conversation. 7/8/07 - Very sleepy, hard time answering questions, difficulty getting out of chair - as the next 20 days progressed, she experienced feeling of weakness, some facial droop, swallowing difficulties, unable to answer questions (stare, then a shrug [I don''t know]), confusion, incontinence, walk very slowly, occasional dragging of foot. Just before she died (approx 17 hours earlier), she described some things that she did at rehab. Her descriptions were rather odd - after she said them, she realized they sounded odd and stated she thought she must be going crazy - she knew something wasn''t right. She went from being able bodied, alert, communicative, capable person to unable to do simple personal tasks. An otherwise healthy person does not have a rapid change as this one without a reason. All tests run came back perfectly normal - 3 Cat scans showed nothing wrong. Blood work - that of a 50 year old. No evidence of stroke. Drs - both primary MD and Hospital staff said vaccine couldn''t have done it. Symptoms occurred w/in 24 hours of getting vaccine. 9/25/07 Received medical records & death certificate from pcp which reveals COD as cardio-respiratory arrest with atrial fibrillation, mitral regurgitation, HTN, hypothyroid, anemia as contributing factors. Medical records reveal patient in usual state of health & on Coumadin for a. fib when received zostavax on 7/6/07 but no lot # provided. Returned to pcp on 7/9/07 after a fall 7/8/07 & now w/trouble ambulating & speech & memory were slow. No hx of neuro problems & no current head injury, but w/bruising of right arm. Dx at that time: syncope. Admitted directly to hospital. Returned to pcp on 7/18 for hospital f/u. Receiving home health RN, PT/OT & was doing poorly w/dysphagia, lethargy/sleepiness & incontinence. Readmitted to hospital directly. 10/9/07 Reviewed hospital medical records which reveal patient experienced fall at AL facility, seen in pcp office & direct admitted to hospi

VAERS ID:290938 (history)  Vaccinated:2007-09-05
Age:  Onset:2007-09-05, Days after vaccination: 0
Gender:Female  Submitted:2007-09-19, Days after onset: 14
Location:Texas  Entered:2007-09-20, Days after submission: 1
Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: None
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0709USA01999
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  SCUN
Administered by: Other     Purchased by: Other
Symptoms: Cerebral haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhagic cerebrovascular conditions (narrow)
Write-up: Information has been received from a physician concerning a female consumer with no pertinent history who on approximately 05-SEP-2007 was vaccinated SC with a 0.65 ml dose of Zostavax. On approximately 05-SEP-2007 the patient developed a cerebral hemorrhage and was hospitalized. The condition was considered to be immediately life-threatening per the physician. No further information was provided. There was no product quality complaint involved. Additional information has been requested.

VAERS ID:290939 (history)  Vaccinated:0000-00-00
Age:68.0  Onset:2007-09-11
Gender:Female  Submitted:2007-09-19, Days after onset: 8
Location:Washington  Entered:2007-09-20, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0709USA02217
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Herpes zoster
SMQs:
Write-up: Information has been received from a physician concerning a 68-year-old female who in the "spring of 2007" was vaccinated with a dose of Zostavax (Oka/Merck) (lot# not available). On 11-SEP-2007 the patient was diagnosed with shingles. Unspecified medical attention was sought. The outcome is reported as not recovered. No product quality complaint was involved. The reporter considered shingles to be disabling or incapacitating. Additional information has been requested.

VAERS ID:291029 (history)  Vaccinated:2007-09-05
Age:66.0  Onset:2007-09-07, Days after vaccination: 2
Gender:Female  Submitted:2007-09-20, Days after onset: 13
Location:Unknown  Entered:2007-09-21, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Allergic reaction to antibiotics
Preexisting Conditions:
Diagnostic Lab Data: None
CDC 'Split Type': WAES0709USA01062
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.0882U SCUN
Administered by: Other     Purchased by: Other
Symptoms: Injection site erythema, Injection site swelling, Pyrexia, Transient ischaemic attack
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Ischaemic cerebrovascular conditions (narrow), Embolic and thrombotic events, arterial (narrow), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow)
Write-up: Information has been received from a pharmacist and technician concerning a 66 year old female with allergic reaction to quinolones and no reported medical history who on 05-SEP-2007 was vaccinated with Zostavax (lot # 658085/0882U). Concomitant therapy included a steroid injection and other unspecified medications. On 07-SEP-2007 the patient experienced fever, swelling and redness at the injection site. The patient sought the medical attention of the pharmacist. On 14-SEP-2007 the patient contacted the pharmacy and reported that she was admitted to the hospital on 11-SEP-2007 for a "mini-stroke". She was released on 13-SEP-2007. The patient is recovering from her events. Additional information has been requested.

VAERS ID:291030 (history)  Vaccinated:0000-00-00
Age:55.0  Onset:0000-00-00
Gender:Male  Submitted:2007-09-20
Location:New York  Entered:2007-09-21, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0709USA01767
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Cellulitis, Inappropriate schedule of drug administration, Injection site erythema, Injection site swelling
SMQs:, Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow)
Write-up: Information has been received from a physician concerning a 55-year-old male who on an unspecified date was vaccinated with a dose of Zostavax. Subsequently, the patient experienced swelling and redness at and around the injection site. The patient was hospitalized because it was possibly thought to be cellulitis. No outcome reported. No product quality complaint was involved. Additional information has been requested.

VAERS ID:291478 (history)  Vaccinated:2007-08-28
Age:91.0  Onset:2007-09-01, Days after vaccination: 4
Gender:Female  Submitted:2007-09-26, Days after onset: 25
Location:Minnesota  Entered:2007-09-27, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: Drug hypersensitivity
Preexisting Conditions:
Diagnostic Lab Data: diagnostic laboratory - results not provided
CDC 'Split Type': WAES0709USA03265
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.0882U SCUN
Administered by: Other     Purchased by: Other
Symptoms: Herpes zoster, Laboratory test, Malaise
SMQs:
Write-up: Information has been received from a consumer concerning her 91 year old mother with a morphine allergy and no pertinent medical history who on 28-AUG-2007 was vaccinated SC with a 0.65 ml dose of Zostavax (Oka/Merck) (Lot#658085/0882U). There was no concomitant medication. On 01-SEP-2007 the patient felt ill and was taken to the emergency room. The next morning 02-SEP-2007 she was admitted into the hospital. Later that day she was diagnosed with shingles. Unspecified "blood tests" were performed. No results were reported. She was discharged from the hospital on 03-SEP-2007. At the time of this report the patient had not recovered. There was no further information provided. There was no product quality complaint involved. This report is serious due to hospitalization. Additional information has been requested.

VAERS ID:291479 (history)  Vaccinated:2007-09-01
Age:  Onset:2007-09-01, Days after vaccination: 0
Gender:Female  Submitted:2007-09-26, Days after onset: 25
Location:New York  Entered:2007-09-27, Days after submission: 1
Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0709USA03423
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  SCUN
Administered by: Other     Purchased by: Other
Symptoms: Oedema peripheral, Respiratory distress, Swelling face
SMQs:, Cardiac failure (broad), Anaphylactic reaction (narrow), Angioedema (narrow), Acute central respiratory depression (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (narrow)
Write-up: Information has been received from a physician concerning a female who in September 2007, was vaccinated SC with a dose of Zostavax. Soon after vaccination the patient experienced respiratory distress. It was reported that the patient''s face and arm was swollen. The physician did send the patient to the emergency room. It was not known if the patient was admitted to the hospital. Unspecified medical attention was sought. A product quality complaint was not involved. The patient''s experiences were considered to be life-threatening and disabling by the reporter. Additional information has been requested.

VAERS ID:291495 (history)  Vaccinated:2007-09-13
Age:79.0  Onset:2007-09-27, Days after vaccination: 14
Gender:Female  Submitted:2007-09-27, Days after onset: 0
Location:Florida  Entered:2007-09-27
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: PMH: diverticulosis, ascending thoracic aortic aneurysm, GERD, hypothyroidism, hyperlipidemia, HTN, osteopenia, lumbar stenosis, vasomotor rhinitis. Hospitalized 1/06 for influenza. Allergic PCN & codeine.
Diagnostic Lab Data: LABS: EKG WNL. Cardiac enzymes (-). CXR WNL. CT of abdomen & pelvis revealed markedly distended urinary bladder. Renal scan WNL. Urine & blood c/s neg. Na 131 (L)
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.0885U0SCRA
Administered by: Private     Purchased by: Private
Symptoms: Abdominal pain lower, Bladder catheter permanent, Bladder obstruction, Blood culture negative, Blood sodium decreased, Cardiac enzymes normal, Chest X-ray normal, Computerised tomogram abnormal, Culture urine negative, Electrocardiogram normal, Herpes zoster, Hyponatraemia, Insomnia, Pain, Post herpetic neuralgia, Rash, Ultrasound kidney normal, Urinary retention
SMQs:, Anaphylactic reaction (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hyponatraemia/SIADH (narrow), Chronic kidney disease (broad), Hypersensitivity (narrow)
Write-up: pt hospitalized 9/20/07-9/25/07 for RLQ pain, developed right T12 HZV rash on 9/27/07-tx''d with Acyclovir 1gm q 8 hr x 7d. Dx. Herpes zoster. 10/5/07 Reviewed hospital medical records which reveal patient experienced right sided abdominal pain & difficulty sleeping 9/19 while out of town. Saw pcp on 9/20 & admitted 9/20-9/25/2007. Urinary catheter inserted w/large residual. Tx w/oral antibiotics. Abdominal pain resolved. FINAL DX: acute abdominal pain of unknown etiology; bladder outlet obstruction; hyponatremia. 11/9/07 Received pcp medical records which included vax record. Confirms lot # as reported. Seen s/p hospitalization on 9/26 & had developed right T12 HXV rash evening before with pain. Tx w/antiviral & pain med. Returned to pcp 10/3 still having pain. Tx w/neurontin. Returned to pcp 10/11. Pain improved w/neurontin & pain med & was to start tapering both off as tolerated. Returned to pcp 10/31 w/increased pain & med increased. FINAL DX: Zoster infection w/post herpetic pain. Per 60 day follow up: R thoracic post herpetic neuritis. 1/12/2010 Right lumbar postherpetic neurolgia on gabapentin.

VAERS ID:291679 (history)  Vaccinated:2007-09-14
Age:62.0  Onset:2007-09-15, Days after vaccination: 1
Gender:Male  Submitted:2007-09-28, Days after onset: 13
Location:Delaware  Entered:2007-10-01, Days after submission: 3
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness: Diabetes
Preexisting Conditions: Prostate cancer
Diagnostic Lab Data: viral culture unknown
CDC 'Split Type': WAES0709USA04028
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Ear pain, Facial palsy, Pharyngitis, Virus culture
SMQs:, Agranulocytosis (broad), Oropharyngeal infections (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious meningitis (broad)
Write-up: Information has been received from a physician concerning a 62-year-old male with no known allergies, who has diabetes, "blood pressure" and a history of prostate cancer, who on 14-SEP-2007 was vaccinated with a dose of Zostavax. No other vaccines were given at that time. On 15-SEP-2007, the patient developed left sided pharyngitis and ear pain. On an unspecified date, the patient was seen in the office and was diagnosed with ulcerative pharyngitis and Bell Palsy. On an unspecified date viral cultures were done. The patient was treated with valacyclovir hydrochloride (VALTREX). The outcome was reported as not recovered. No product quality complaint was involved. The reporter considered ulcerative pharyngitis and Bells Palsy to be disabling and an other important medical event. Additional information has been requested.

VAERS ID:291822 (history)  Vaccinated:2007-09-05
Age:  Onset:2007-09-09, Days after vaccination: 4
Gender:Female  Submitted:2007-10-01, Days after onset: 22
Location:Oregon  Entered:2007-10-02, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Lipitor
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: serum creatine kinase normal
CDC 'Split Type': WAES0709USA03681
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Blood creatine phosphokinase normal, Muscle spasms, Myalgia
SMQs:, Rhabdomyolysis/myopathy (broad), Dystonia (broad), Eosinophilic pneumonia (broad)
Write-up: Information has been received from a physician concerning a female who on 05-SEP-2007 was vaccinated with a dose of Zostavax. Concomitant therapy included atorvastatin calcium (LIPITOR). On 09-SEP-2007 the patient developed muscle pain and muscle spasm in her trapezius and thigh muscles. The patient went to the emergency room. The patient''s muscle pain and muscle spasm persisted and was considered to be disabling. The patient''s Creatine Kinase level was within normal limits. No further information was provided. There was no product quality complaint involved. Additional information has been requested. The reporter considered the patient''s muscle spasms and pain to be disabling.

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18   next

New Search

Link To This Search Result:
http://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=9&VAX[]=VARZOS&SERIOUS=ON


Copyright © 2014 National Vaccine Information Center. All rights reserved.
407-H Church Street, Vienna, Virginia 22180